Management strategy of vestibular schwannoma in neurofibromatosis type 2

Otology and Neurotology

Volumn 32, Issue 7, 2011, Pages 1163-1170

  Odat, Haitham Ahmad ^a   Piccirillo, Enrico ^b   Sequino, Giuliano ^b   Taibah, Abdelkader ^b   Sanna, Mario ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b GRUPPO OTOLOGICO   (Italy)

Author keywords

Auditory brain stem implantation; Cochlear implantation; Hearing preservation surgery; Neurofibromatosis type 2; Vestibular schwannoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COCHLEA PROSTHESIS; FACIAL NERVE; FEMALE; HUMAN; IMPLANTATION; MALE; MIDDLE AGED; NEUROFIBROMATOSIS; NEUROMA; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; COCHLEAR IMPLANTATION; COCHLEAR IMPLANTS; FACIAL NERVE; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 2; NEUROMA, ACOUSTIC; RETROSPECTIVE STUDIES;

EID: 80052265427     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3182267f17     Document Type: Article

References (33)

1. Welling DB, Guida M, Goll F, et al. Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwanno-mas. Hum Genet 1996;98:189-93. (Pubitemid 26237502)
2. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofi-bromatosis type 2. Nature 1993;363:515-21. (Pubitemid 23186636)
3. Baser ME, Ragge NK, Riccardi VM, et al. Phenotype variability in monozygotic twins with neurofibromatosis 2. Am J Med Genet 1996;64:563-7.
4. Parry DM, Eldridge R, Kaiser-Kupfer MI, et al. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 1994;52: 450-61. (Pubitemid 24298996)
5. Slattery WH III. Neurofibromatosis 2. In: Brackmann DE, Shelton C, Arriaga MA. Otologic Surgery, 3rd ed. Philadelphia, PA: Elsevier press, 2010:691-7001.
6. Brackmann DE, Fayad JN, Slattery WH III, et al. Early proactive management of vestibular schwannomas in neurofibromatosis type 2. Neurosurgery 2001;49:274-83. (Pubitemid 32721055)
7. Samii M, Matthies C, Tatagiba M. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerves function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2. Neurosurgery 1997;40:696-705.
8. Kanzaki J, Tos M, Sanna M, et al. New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol 2003;24:642-8. (Pubitemid 36886281)
9. Sanna M, Guida M, Merkus P. Auditory brainstem implants in NF2 patients. Results and review of the literature. Audiol Neurotol (in press).
10. Vincenti V, Pasanisi E, Guida M, Di Trapani G, Sanna M. Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation. Audiol Neurootol 2008;13: 273-80. (Pubitemid 351799097)
11. Husseini ST, Piccirillo E, Taibah A, Paties CT, Rizzoli R, Sanna M. Malignancy in vestibular schwannoma after stereotactic radiotherapy: a case report and review of the literature. Laryngoscope 2011; 121:923-8.
12. National Institutes of Health Consensus Development Conference: Statement on Acoustic Neuroma. Bethesda, MD: National Institutes of Health. 1994.
13. Slattery WH 3rd, Fisher LM, Hitselberger W, Friedman RA, Brackmann DE. Hearing preservation surgery for neurofibromatosis type 2-related vestibular schwannoma in pediatric patients. J Neuro-surg 2007;106:255-60.
14. Slattery WH, Brackmann DE, Hitselberger WE. Hearing preservation in neurofibromatosis type 2. Am J Otol 1998;19:638-43.
15. Samii M, Gerganov V, Samii A. Microsurgery management of vestibular schwannomas in neurofibromatosis type 2: indications and results. Prog Neurol Surg 2008;21:169-75.
16. Phi JH, Kim DG, Chung HT, Lee J, Paek SH, Jung HW. Radio-surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation. Cancer 2009;115:390-8.
17. Mathieu D, Kondziolka D, Flickinger JC, et al. Stereotactic radio-surgery for vestibular schwannomas in patients with neurofi-bromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 2007;60:460-8; discussion 468-70. (Pubitemid 46339181)
18. Briggs RJ, Brackmann DE, Baser ME, Hitselberger WE. Comprehensive management of bilateral acoustic neuromas: current perspectives. Arch Otolaryngol Head Neck Surg 1994;120:1307-14. (Pubitemid 24378570)
19. Jackler RK, Pitts LH. Selection of surgical approach to acoustic neuroma. Otolaryngol Clin North Am 1992;25:361-87.
20. MacNally SP, Rutherford SA, King AT, et al. Outcome from surgery for vestibular schwannomas in children. Br J Neurosurg 2009; 23:226-31.
21. Slattery WH III, Brackmann DE. Hearing preservation and restoration in CPA tumor surgery. Neurosurg Q 1997;7:169-82. (Pubitemid 27417917)
22. Black FO, Brackmann DE, Hitselberger WE, Purdy J. Preservation of auditory and vestibular function after surgical removal of bilateral vestibular schwannomas in a patient with Neurofibromatosis Type 2. Am J Otol 1995;16:431-43.
23. Sanna M, Mancini F, Russo A, Taibah A, Falcioni M, Di Trapani G. Atlas of Acoustic Neurinoma Microsurgery, 2nd ed. New York, NY: Thieme press, 2011:244-50.
24. Piccirillo E, Guida M, Flanagan S, Lauda L, Fois P, Sanna M. CNAP to predict functional cochlear nerve preservation in NF-2: cochlear implant or auditory brainstem implant. Skull Base 2008;18: 281-7.
25. Schwartz MS, Otto SR, Brackmann DE, Hitselberger WE, Shannon RV. Use of a multichannel auditory brainstem implant for neuro-fibromatosis type 2. Stereotact Funct Neurosurg 2003;81:110-4. (Pubitemid 38209824)
26. Ahsan S, Telischi F, Hodges A, et al. Cochlear implantation concurrent with translabyrinthine acoustic neuroma resection. Laryngoscope 2003;113:472-4. (Pubitemid 36292872)
27. Aristegui M, Denia A. Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in an only hearing ear: report of two cases (neurofibromatosis type 2 and unilateral vestibular schwannoma). Otol Neurotol 2005;26:205-10. (Pubitemid 40418654)
28. Neff BA, Wiet RM, Lasak JM, et al. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up. Laryngoscope 2007;117:1069-72. (Pubitemid 46869847)
29. Lustig LR, Yeagle J, Driscoll CW, Blevins N, Francis H, Niparko JK. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma. Otol Neurotol 2006;27:512-8.
30. Belal AA. Is cochlear implantation possible after acoustic tumor removal? Otol Neurotol 2001;22:497-500.
31. Facer GW, Facer ML, Fowler CM, Brey RH, Peterson AM. Cochlear implantation after labyrinthectomy. Am J Otol 2000;21:336-40. (Pubitemid 30305029)
32. Behr R, Muller J, Shehata-Dieler W, et al. The high rate CIS auditory brainstem implant for restoration of hearing in NF-2 patients. Skull Base 2007;17:91-107.
33. Grayeli AB, Kalamarides M, Bouccara D, Ambert-Dahan E, Sterkers O. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients. Otol Neurotol 2008;29:1140-6.